EuroEyes International Eye Clinic Limited provided preliminary unaudited consolidated earnings guidance for the year ended 31 December 2023. For the period, the group expects to record: (i) a profit attributable to owners of the Company in the range of approximately HKD 128 million to HKD 135 million, as compared to approximately HKD 89.5 million for the year ended 31 December 2022 ("Last Year"); and (ii) the earnings before interest, taxes, depreciation and amortisation ("EBITDA") for the Year in the range of approximately HKD 278 million to HKD 290 million, representing an increase in the range of approximately 30% to 36%, as compared to approximately HKD 214 million for the Last Year.
EuroEyes International Eye Clinic Limited
Equities
1846
KYG3224D1088
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.46 HKD | 0.00% | -5.86% | +4.80% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.80% | 237M | |
-20.63% | 3.03B | |
-13.32% | 2.87B | |
-58.49% | 2.13B | |
-46.75% | 175M | |
-35.20% | 113M |
- Stock Market
- Equities
- 1846 Stock
- News EuroEyes International Eye Clinic Limited
- Euroeyes International Eye Clinic Limited Provides Preliminary Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023